Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.
about
Selection and characterization of a promoter for expression of single-copy recombinant genes in Gram-positive bacteriaIn vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordoniiSurface display of recombinant proteins on Bacillus subtilis spores.Biotechnological approaches to fight pathogens at mucosal sites.Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody.Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants.Expression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response.Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria.Non-recombinant display of the B subunit of the heat labile toxin of Escherichia coli on wild type and mutant spores of Bacillus subtilis.Immunological approaches against human chorionic gonadotropin for control of fertility and therapy of advanced-stage cancers expressing hCG/subunits.Mucosal vaccine delivery by non-recombinant spores of Bacillus subtilis.Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domainsStimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii.Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine.In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.
P2860
Q24801254-F709B5E2-A84B-4DF6-B8E9-046FB4F389A3Q24804214-A5606011-997F-48C2-A02A-CA391E3D9A41Q33554407-1A55DA6A-D97C-471C-B4E2-1B3B833C81A3Q34351883-8C27F289-DADA-446E-B4F9-A108562FD529Q34552312-193249A3-88EF-4D87-8B0A-FCDAAABACA35Q35042482-DC5B4190-A9D3-4B55-811F-4CA132344E14Q36746887-1CBF4F7A-8854-40B0-94C9-ECE05CF2A0BCQ36881875-A0AFAF62-80F9-4817-BD68-9FBE38A3A5E0Q36974497-63C28CF1-ADAE-4D19-8EB9-BF8431248E8EQ37276110-BDF1FAD0-C7E0-41D2-A722-06FFA5BDFCE5Q37866362-2AE07625-9ADB-4C78-8DD0-4EC330622192Q38238919-C9D4D3B2-4FEE-4EE5-9CE5-63845EF349DFQ39179768-6339953C-F874-4144-9AED-0F044CF5C52AQ39519776-F7E47CB9-36B6-409A-9C98-18C6BE078B9CQ40234321-927FC5EB-A152-42B1-BD97-363CE797AE4BQ40436195-9D4946D1-AACB-4551-99D4-7A53C871C219Q42581247-AD87C312-7326-4AED-8871-539A3CC99E39
P2860
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@ast
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@en
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@nl
type
label
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@ast
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@en
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@nl
prefLabel
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@ast
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@en
Immunogenicity of the B monome ...... ace of Streptococcus gordonii.
@nl
P2860
P50
P1476
Immunogenicity of the B monome ...... face of Streptococcus gordonii
@en
P2093
P2860
P304
P356
10.1128/IAI.68.2.760-766.2000
P407
P50
P577
2000-02-01T00:00:00Z